Ahead of the winter respiratory virus season, many parents were relieved the U.S. Food and Drug Administration approved a shot to combat respiratory syncytial virus, or RSV, for infants and toddlers this summer.
Nov 24, 2023
0
0
The chikungunya virus is widespread in tropical regions, where it is spread to humans by mosquitoes of the genus Aedes. Chikungunya is characterized by high fever, headache, muscle and joint pain, rash, and sometimes diarrhea. ...
Nov 22, 2023
0
0
COVID-19 remains a threat as a virus variant has been spreading steadily around the globe, the World Health Organisation said Tuesday.
Nov 21, 2023
0
1
Children who had preexisting health problems or who lived in the Southern United States had a higher risk for severe health outcomes from acute COVID-19 infections, according to researchers at UT Southwestern Medical Center. ...
Nov 21, 2023
0
2
Over a third of American adults are worried that they or someone in their family will get the seasonal flu, COVID-19, or RSV (respiratory syncytial virus) in the next three months, according to a new health survey from the ...
Nov 20, 2023
0
1
Respiratory syncytial virus (RSV) is a common virus that seriously affects vulnerable populations such as infants, young children and older adults. Dr. Wasem Alsabbagh, associate professor at the University of Waterloo School ...
Nov 20, 2023
0
1
The recent global mpox outbreak trained a bright spotlight on the need for safe and effective Orthopoxvirus vaccines, especially in light of continuously looming zoonotic threats and the potential for these pathogens to spread ...
US health authorities on Thursday approved the world's first vaccine for chikungunya, a virus spread by infected mosquitoes that the Food and Drug Administration called "an emerging global health threat."
Nov 10, 2023
0
13
Marta Butrym from the Center for Infectious Medicine (CIM), at the department of Medicine, Huddinge (MedH), is defending her thesis, "Novel vaccines and antiviral treatments for enterovirus induced infections and disease," ...
Nov 6, 2023
0
0
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
